Kandera Reinhard 4
4 · HOOKIPA Pharma Inc. · Filed Feb 1, 2022
Insider Transaction Report
Form 4
Kandera Reinhard
DirectorChief Financial Officer
Transactions
- Award
Common Stock
2022-02-01$3.00/sh+14,056$42,168→ 16,092 total - Award
Stock Option (Right to Buy)
2022-02-01$3.00/sh+23,427$70,281→ 23,427 totalExercise: $1.50Exp: 2032-01-31→ Common Stock (23,427 underlying)
Footnotes (2)
- [F1]The Reporting Person was awarded 14,056 unrestricted shares of common stock as a portion of their base salary for the six month ending June 30, 2022.
- [F2]This stock option is fully vested.